Tag Archives: Advanced

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers Print this page INDIANAPOLIS, May 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Retevmo™ (selpercatinib, 40 mg & 80 mg capsules), the first therapy specifically indicated for the treatment of adult patients with… Read More »

TKC digital signs strategic partnership agreement with Contexta360 to add advanced AI and speech analytics to their portfolio

LONDON – 24th May 2019 — Contexta360, a leading speech analytics and conversational computing company, today announced it has signed a reseller agreement with TKC digital, a leading knowledge management vendor and call centre consultancy. Contexta360 supports TKC digital by analysing and improving the customer service journey. The agreement leverages TKC digital’s knowledge management technology,… Read More »